You are currently viewing a new version of our website. To view the old version click .
  • Current Oncology is published by MDPI from Volume 28 Issue 1 (2021). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Multimed Inc..

Current Oncology, Volume 27, Issue 3

June 2020 - 27 articles

  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
  • You may sign up for email alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.

Articles (27)

  • Article
  • Open Access
7 Citations
1,224 Views
8 Pages

Real-World Impact of Laparoscopic Surgery for Rectal Cancer: A Population-Based Analysis

  • A.E. Drohan,
  • C.M. Hoogerboord,
  • P.M. Johnson,
  • G.J. Flowerdew and
  • G.A. Porte

1 June 2020

Background: Randomized trials have demonstrated equivalent oncologic outcomes and decreased morbidity in patients with rectal cancer who undergo laparoscopic surgery (LapSx) compared with open surgery (OpenSx). The objective of the present study was...

  • Article
  • Open Access
10 Citations
1,426 Views
6 Pages

Prognosis and Clinicopathologic Features in Patients with Gastric Stump Cancer after Curative Surgery

  • C.Y. Kung,
  • W.L. Fang,
  • R.F. Wang,
  • C.A. Liu,
  • A.F.Y. Li,
  • C.W. Wu,
  • Y.M. Shyr,
  • S.C. Chou and
  • K.H. Huang

1 June 2020

Background: Gastric stump (“remnant”) cancer is the development of a malignancy related to previous gastric surgery. Prognosis in gastric stump cancer, compared with that in primary gastric cancer, is still controversial. Methods: From January 1988 t...

  • Article
  • Open Access
1 Citations
1,266 Views
6 Pages

1 June 2020

Background: Studies in the adjuvant setting suggest that the timing of breast cancer diagnosis, surgery, and chemotherapy might affect outcomes. In the neoadjuvant setting, data exploring whether expeditious neoadjuvant chemotherapy (nac) after diagn...

  • Article
  • Open Access
9 Citations
1,603 Views
5 Pages

1 June 2020

Background: Despite universal access to health care in Canada, there are disparities relating to social determinants of health that contribute to discrepancies between rural and urban areas in cancer incidence and outcomes. Given that Canada has one...

  • Article
  • Open Access
5 Citations
1,109 Views
7 Pages

Tyrosine Kinase Inhibitors Significantly Improved Survival Outcomes in Patients with Metastatic Gastrointestinal Stromal Tumour: A Multi-Institutional Cohort Study

  • A. Deruchie Tan,
  • K. Willemsma,
  • A. MacNeill,
  • K. DeVries,
  • A. Srikanthan,
  • C. McGahan,
  • T. Hamilton,
  • H. Li,
  • C.D. Blanke and
  • C.E. Simmons

1 June 2020

Background: The real-world impact of tyrosine kinase inhibitors (tkis) in clinical practice for gastrointestinal stromal tumour (gist) has not been extensively reported. We sought to assess how outcomes have changed over the eras and to evaluate the...

  • Article
  • Open Access
8 Citations
1,380 Views
11 Pages

1 June 2020

Background: In this research, we used the mediastinal lymph node reclassification proposed by the International Association for the Study of Lung Cancer (iaslc) to screen for patients with pathologic N2 (pN2) non-small-cell lung cancer (nsclc) who mi...

  • Article
  • Open Access
8 Citations
1,298 Views
13 Pages

Investigating Epidemiologic Trends and the Geographic Distribution of Patients with Anal Squamous Cell Carcinoma throughout Canada

  • L. Cattelan,
  • F.M. Ghazawi,
  • M. Le,
  • E. Savin,
  • A. Zubarev,
  • F. Lagacé,
  • D. Sasseville,
  • K. Waschke and
  • I.V. Litvinov

1 June 2020

Background: Anal cancer is a rare disease, constituting 0.5% of new cancer cases in the United States. The most common subtype is squamous cell carcinoma (scc). Studies in several developed nations have reported on an increasing incidence of anal can...

  • Article
  • Open Access
4 Citations
1,262 Views
6 Pages

1 June 2020

Background: In Canada, there is growing evidence that oncology clinical trials units (ctus) and programs face serious financial challenges. Investment in cancer research in Canada has declined almost 20% in the 5 years since its peak in 2011, and the...

  • Article
  • Open Access
7 Citations
1,444 Views
5 Pages

1 June 2020

Background: The emergence of covid-19 has the potential to change the way in which the health care system can accommodate various patient populations and might affect patients with non–covid-19 problems. The Quebec Lung Cancer Network, which oversees...

  • Article
  • Open Access
12 Citations
1,639 Views
8 Pages

Locoregional Management of in-Transit Metastasis in Melanoma: An Ontario Health (Cancer Care Ontario) Clinical Practice Guideline

  • F.C. Wright,
  • S. Kellett,
  • N.J. Look Hong,
  • A.Y. Sun,
  • T.P. Hanna,
  • C. Nessim,
  • C.A. Giacomantonio,
  • C.F. Temple-Oberle,
  • X. Song and
  • T.M. Petrella

1 June 2020

Objective: The purpose of this guideline is to provide guidance on appropriate management of satellite and in-transit metastasis (itm) from melanoma. Methods: The guideline was developed by the Program in Evidence-Based Care (pebc) of Ontario Health...

of 3

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
Curr. Oncol. - ISSN 1718-7729